Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Obstructive Sleep Apnea patients adhering to Continuous positive Airway Pressure: A randomized trial.

< BACK TO ARCHIVE


2020 Oct 26


Chest


http://www.ncbi.nlm.nih.gov/pubmed/33121980?dopt=Abstract

Obstructive Sleep Apnea patients adhering to Continuous positive Airway Pressure: A randomized trial.

Authors

Obstructive Sleep Apnea patients adhering to Continuous positive Airway Pressure: A randomized trial.
Pépin J-L, Georgiev O, Tiholov R, Attali V, Verbraecken J, Buyse B, Partinen M, Fietze I, Belev G, Dokic D, Tamisier R, Lévy P, Lecomte I, Lecomte J-M, Schwartz J-C, Dauvilliers Y
Chest. 2020 Oct 26.
PMID: 33121980.

Abstract

Excessive daytime sleepiness (EDS) in individuals with obstructive sleep apnea syndrome persisting despite good adherence to continuous positive airway pressure (CPAP) is a disabling condition. Pitolisant is a selective histamine H3-receptor antagonist with wake-promoting effects.
Read This Paper